Lataa...
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
INTRODUCTION: The European Medicines Agency has suspended the use of ulipristal acetate (UPA) in the treatment of uterine fibroids and is reassessing its association with a risk of liver injury. OBJECTIVES: Our objectives were to characterize the post-marketing reporting of drug-induced liver injury...
Tallennettuna:
| Julkaisussa: | Drug Saf |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686198/ https://ncbi.nlm.nih.gov/pubmed/32748236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-020-00975-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|